From January 1, 2023 to March 31, 2023, the company has repurchased 0 shares, representing 0% for CNY 0 million. With this, the company has completed the repurchase of 2,559,700 shares, representing 0.27% for CNY 29.99 million under the buyback announced on June 10, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
13 CNY | +1.72% | +6.91% | +6.91% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+6.91% | 168.81Cr | |
+34.35% | 71TCr | |
+29.39% | 58TCr | |
-3.49% | 36TCr | |
+20.15% | 33TCr | |
+6.19% | 29TCr | |
+14.11% | 24TCr | |
-3.03% | 21TCr | |
+10.02% | 21TCr | |
+9.21% | 17TCr |
- Stock Market
- Equities
- 603567 Stock
- News Heilongjiang ZBD Pharmaceutical Co., Ltd.
- Tranche Update on Heilongjiang ZBD Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on June 10, 2022.